Alexander Nast

发表

Definition of treatment goals for moderate to severe psoriasis: a European consensus

C. Griffiths, T. Nijsten, L. Iversen, 2010, Archives of Dermatological Research.

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

T. Zuberbier, G. Canonica, D. Larenas-Linnemann, 2018, Allergy.

The natural history of actinic keratosis: a systematic review

E. Stockfleth, A. Nast, R. Werner, 2013, The British journal of dermatology.

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

T. Zuberbier, G. Canonica, F. Simons, 2014, Allergy.

Efficacy of systemic therapies for moderate‐to‐severe psoriasis: a systematic review and meta‐analysis of long‐term treatment

J. Schmitt, B. Rzany, A. Nast, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efficacy and safety of systemic treatments for moderate‐to‐severe psoriasis: meta‐analysis of randomized controlled trials

E. Haufe, J. Schmitt, A. Nast, 2014, The British journal of dermatology.

Executive summary of the methods report for ‘The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update’

T. Zuberbier, A. Nast, C. Dressler, 2018, Allergy.

A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis

J. Schmitt, K. Kragballe, K. Reich, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument

B. Marinovic, A. Nast, S. Rosumeck, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

L. Naldi, H. Hönigsmann, M. Hussain, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

A patient‐centred approach to biological treatment decision making for psoriasis: an expert consensus

G. Girolomoni, A. Nast, R. Strohal, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic

Elizabeth J Horn, M. Lebwohl, E. Horn, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017

E. D. De Jong, E. Prens, H. Thio, 2019, The British journal of dermatology.

European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC

P. Gisondi, K. Papp, K. Reich, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Methods Report: European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – update 2015 – EDF in cooperation with EADV and IPC

A. Nast, S. Rosumeck, A. Jacobs, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Strategies for improving the quality of care in psoriasis with the use of treatment goals – a report on an implementation meeting

K. Kragballe, K. Reich, U. Mrowietz, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.